Skip to product information
1 of 1

FDA NDA 208232: CDER€™s DGE Division's response to OOPD regarding Mycapssa (dated 4/5/24)

FDA NDA 208232: CDER€™s DGE Division's response to OOPD regarding Mycapssa (dated 4/5/24)

Regular price $51.94 USD
Regular price Sale price $51.94 USD
Sale Sold out

CDER€™s DGE Division response (dated 4/5/24) to the Office of Orphan Drug Products (OOPD)'s consult request regarding Mycapssa (octreotide) (dated July 23, 2020).

5 pages

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome